Novel methods of treating hearing loss
US-2024390323-A1 · Nov 28, 2024 · US
US10117840B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10117840-B2 |
| Application number | US-201515316742-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 5, 2015 |
| Priority date | Jun 6, 2014 |
| Publication date | Nov 6, 2018 |
| Grant date | Nov 6, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This application describes a compound represented by Formula (I): (I) wherein: Y is a biologically active organic core group comprising one or more of an aryl group, a heteroaryl aryl group, a nonaromatic hydrocarbyl group, and a nonaromatic heterocyclic group, to which Z is covalently bonded; n is 1, 2, 3, 4 or 5; m is 1 or 2; Z is O, NR, or N; X 1 is a covalent bond or —CH 2 CH 2 —, X 2 is O or NR; and R comprises H or a substituted or unsubstituted group selected from an aryl group, a heteroaryl aryl group, a nonaromatic hydrocarbyl group, and a nonaromatic heterocyclic group. Methods of preparing the compounds, methods of using the compounds, and pharmaceutical compositions comprising the compounds are described as well.
Opening claim text (preview).
We claim: 1. An amino protected O-fluorosulfonyl-L-tyrosine of formula: wherein “Fmoc” represents a 9-fluorenylmethyloxycarbonyl protecting group. 2. A polypeptide comprising an O-fluorosulfonyl-L-tyrosine residue. 3. The polypeptide of claim 2 , wherein the polypeptide is selected from the group consisting of oxytocin, indolicin, thymopentin, and arginine vassopressin, in which the tyrosine residue thereof is replaced by an O-fluorosulfonyl-L-tyrosine residue. 4. A method of preparing a sulfated polypeptide comprising contacting the polypeptide of claim 2 with cesium carbonate and a solution of ammonia in methanol to selectively hydrolyze the fluoro group of the fluorosulfonyl-L-tyrosine residue and from a sulfated tyrosine residue therefrom.
condensed with carbocyclic rings or ring systems · CPC title
of the sex hormones · CPC title
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
of the suprarenal hormones · CPC title
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.